Analystreport

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at Piper Sandler from $347.00 to $261.00. They now have an "overweight"

Vertex Pharmaceuticals Incorporated  (VRTX) 
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com